Precision Medicine and Functional Genomics
Virtual Meeting 202014.25 CPD HOURS
Dates: December 5-7, 2020
- Dec 5, 2020 Local Time 14:00 – 19:50 | EST 07:00 – 12:50 | GMT 11:00 - 16:50
- Dec 6, 2020 Local Time 14:00 – 19:50 | EST 07:00 – 12:50 | GMT 11:00 - 16:50
- Dec 7, 2020 Local Time 14:00 – 19:50 | EST 07:00 – 12:50 | GMT 11:00 - 16:50
Sidra Medicine is proud to support Qatar’s National Vision 2030 to building a knowledge-based economy particularly in biomedical and health sciences. We are actively engaging clinical and scientific expertise to establish a leading model for Precision Medicine in the region and we want you to join us in this year’s iteration FG 2020 where we will deliver live and on-demand programming, selected abstract sessions as well as special sessions on COVID-19. FG 2020 will also highlight the biotech/pharma industry’s role in precision medicine.
Our ambition to advance precision medicine in Qatar, combines research, education and clinical practice to successfully tackle conditions affecting women and children in Qatar. In line with this vision, FG 2020 will bring together researchers, academics, healthcare professionals, policy makers and the community members to explore the latest developments and innovations in genomics research and how they translate into precision medicine solutions.
This activity was planned by and for the healthcare team, and learners will receive 14.25 hours Qatar Council of Healthcare Practitioner (QCHP) credits for learning and change.
In support of improving patient care, Sidra Medicine is jointly accredited by the Accreditation, Council for Continuing Medical Education (ACCME), the Accreditation Council far Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Scientific Planning Committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators, and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.
